Alphatec Holdings, Inc.

NASDAQ:ATEC

Medical - Devices

Healthcare
$7.06 +3.97%

+$0.33 today

Market cap
$1.10B
Beta
0.87
P/E (TTM)
-10.5
EPS (TTM)
-$0.81
52W Low $6.82High $23.29

Volume 2.80M

Average 3.21M

ATEC Depreciation & Amortization

Non-cash asset write-downs added back to net income because no cash left the business.

Alphatec Holdings, Inc.NASDAQ: ATEC

Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026

Depreciation & amortization dips below year-ago levels

Q1 FY2026 depreciation & amortization of $20.46M fell 3.4% year over year, behind the +3.7% change in trailing-twelve-month depreciation & amortization. Sequentially, it fell 25.3% from the prior quarter. Over 3 fiscal years it compounded at +33.7% a year.

Context

  • Depreciation & amortization amounted to 13.8% of revenue in FY2025, up 0.1 pp from a year earlier.
  • Depreciation & amortization increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -3.4% toward the trailing-twelve-month pace of +3.7%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$20.46M-25.3% QoQ
Last fiscal yearDec 2025
$105.08M+26.1% YoY
LTMMar 2026
$88.73M+3.7% YoY
Depreciation & Amortization past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-3.4%——
1 year+26.1%——
3-year CAGR+33.7%——
5-year CAGR——
10-year CAGR——

Depreciation & Amortization history

USD · from the cash flow

Latest · FY2025
105.08M USD
Year-over-year change
+26.1%
4-year CAGR
+36.6%

Depreciation & Amortization vs competitors

How ATEC compares with its peers on the latest reported figures

  • ATEC's LTM Mar 2026 depreciation & amortization of $88.73M is the 6th largest of the 7 companies compared; the peer median is $216.94M.
  • Its year-over-year change of +3.7% is the 5th highest of 7, against a peer median of +6.4%.
  • Depreciation & amortization amounts to 11.3% of revenue for ATEC, versus a peer median of 9.1%.
ATEC Competitors Peer median
Depreciation & Amortization for ATEC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SYKStryker CorporationLTM Jun 2026$1.25B +13.3%+6.1%4.8%
SNNSmith & Nephew plcFY2025$573M +3.2%+1.5%9.3%
GMEDGlobus Medical, Inc.LTM Jun 2026$280.81M +3.3%+59.5%8.9%
IARTIntegra LifeSciences Holdings CorporationLTM Mar 2026$153.07M +3.8%+8.7%9.3%
OFIXOrthofix Medical Inc.LTM Mar 2026$136.43M +43.1%+37.4%16.5%
ATECAlphatec Holdings, Inc.LTM Mar 2026$88.73M +3.7%+33.7%11.3%
XTNTXtant Medical Holdings, Inc.LTM Mar 2026$4.68M +9.1%+59.3%3.8%
Peer median (excluding ATEC) $216.94M+6.4%+23.1%9.1%

Competitors are the stored peer set for ATEC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(143.03M)(151.29M)(186.64M)(162.12M)(143.36M)
Depreciation & Amortization30.17M43.93M59.68M83.32M105.08M
Deferred Income Tax00000
Stock-Based Compensation36.45M40.56M81.24M73.28M73.72M
Change in Working Capital(25.06M)(23.94M)(54.18M)(67.27M)(20.13M)
Accounts Receivables(10.14M)(18.83M)(12.8M)(14.59M)(21.88M)
Inventory(27.75M)(20.7M)(45.56M)(54.66M)13.54M
Accounts Payables757K9.8M6.99M9.67M(11.16M)
Other Working Capital12.08M5.8M(2.81M)(7.7M)(629K)
Other Non-Cash Items28.15M15.61M21.41M28.15M29.92M
Operating Cash Flow(73.32M)(75.13M)(78.49M)(44.65M)45.23M
Capital Expenditures(68.54M)(58.28M)(86.98M)(93.14M)(42.46M)
Acquisitions (Net)(83.23M)0(55M)00
Purchases of Investments(5.99M)0000
Sales of Investments00000
Other Investing Activities0(8.83M)(6.47M)(9.91M)(10.96M)
Investing Cash Flow(157.76M)(58.28M)(141.98M)(93.14M)(53.41M)
Debt Repayment271.25M33.69M149.66M58.8M74.81M
Common Stock Issued131.83M(3.04M)212.12M(560K)515K
Common Stock Repurchased(30.96M)0000
Dividends Paid00000
Other Financing Activities(60.15M)584K(4.86M)(2.03M)(45.31M)
Financing Cash Flow311.97M31.23M356.92M56.21M30.02M
Effect of Forex Changes(1.4M)(366K)(185K)(551K)128K
Net Change in Cash79.48M(102.55M)136.27M(82.13M)21.97M
Free Cash Flow(141.86M)(133.41M)(165.46M)(137.79M)2.78M

Alphatec Holdings, Inc.

NASDAQ:ATEC

Intrinsic Alpha fair value

Locked

Current Price

$7.06

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.